The results revealed that GPx2 expression impacted kynurenines (KYNU)-mediated metabolism, in addition to the involvement of the reactive oxygen species (ROS)-mediated KYNU-kyn-AhR signaling pathway in gastric cancer progression and metastasis following GPx2 knockdown. This evidence concerns the gene GPX2 and gastric cancer.